⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL771298 | 1.00 | — | — | |
| SCHEMBL12245522 | 1.00 | — | — | |
| SCHEMBL21825776 | 0.87 | — | — | |
| SCHEMBL21825774 | 0.87 | — | — | |
| SCHEMBL13038277 | 0.86 | — | — | |
| SCHEMBL25012007 | 0.85 | — | — | |
| SCHEMBL2221193 | 0.85 | — | — | |
| SCHEMBL1338762 | 0.85 | MEN1 (0.56) | — | |
| SCHEMBL1338765 | 0.85 | MEN1 (0.56) | — | |
| SCHEMBL1336590 | 0.85 | NPC1 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3862083-B1 | CATALYST FOR ASYMMETRIC HYDROGENATION OF COMPOUND CONTAINING CARBON DOUBLE BOND | GLACEUM INC (KR) | 2023-03-08 | — | — | EP | disclosed |
| US-11420988-B2 | Catalyst for asymmetric hydrogenation of compound containing carbon double bond | GLACEUM, INC. (KR) | 2022-08-23 | — | — | US | disclosed |
| US-20210395282-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION OF COMPOUND CONTAINING CARBON DOUBLE BOND | GLACEUM, INC. (KR) | 2021-12-23 | — | — | US | disclosed |
| EP-3862083-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION OF COMPOUND CONTAINING CARBON DOUBLE BOND | Glaceum, Inc. (KR) | 2021-08-11 | — | — | EP | disclosed |
| WO-2020071818-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION OF COMPOUND CONTAINING CARBON DOUBLE BOND | 주식회사 글라세움 | 2020-04-09 | — | — | WO | disclosed |
| US-7833993-B2 | Immunomodulatory compounds and methods of use thereof | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2010-11-16 | — | — | US | disclosed |
| US-7833993-B2 | Immunomodulatory compounds and methods of use thereof | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2010-11-16 | — | — | US | disclosed |
| US-7560584-B2 | Immunomodulatory compounds and methods of use thereof | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2009-07-14 | — | — | US | disclosed |
| US-7560584-B2 | Immunomodulatory compounds and methods of use thereof | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2009-07-14 | — | — | US | disclosed |
| US-6835846-B2 | The present invention provides an aliphatic compound represented by the following formula (I) or pharmacologically acceptable salts thereof: the aliphatic compound being an optical isomer of the (2R,3S,2'S) configuration when the | MARUHA CORPORATION (JP) | 2004-12-28 | — | — | US | disclosed |
| US-20040014816-A1 | Novel aliphatic compounds, process for their preparation and their usage | MARUHA NICHIRO SEAFOODS, INC. (JP) | 2004-01-22 | — | — | US | disclosed |
| EP-1325904-A1 | NOVEL ALIPHATIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USAGE | Maruha Corporation (JP) | 2003-07-09 | — | — | EP | disclosed |